Abstract
Treatment of Community-acquired pneumonia remains an actual problem in modern medicine, especially in patients with concomitant pathology of internal organs. In particular, this applies to patients with chronic renal failure, which often remain in conditions of subureemia. On the background of the latter, the other concomitant conditions and sufferings often develop, such as uremic pneumonitis, chronic hyperhydration of the pulmonary tissue, the syndrome of night apnoea and hypoxemia, associated with the hemodialysis sessions. All this creates a favorable background for the additional bacterial infection and the development of Community-acquired pneumonia. The sooner the diagnosis of pneumonia is established, the earlier the ethiotropic treatment hasstarted, the more effective the treatment is in outpatient settings. In the clinical case, the efficacy and appropriateness of administration of Rovamycin (spiramycin) as a medication for antibiotic therapy in the treatment of Community-acquired pneumonia in patients with chronic renal failure has been proven.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.